Article
Interleukin-18 promoter polymorphisms in type 1 diabetes.
Diabetes - 1 Nov 2002
Kretowski Adam, Mironczuk Katarzyna, Karpinska Anna, Bojaryn Urszula, Kinalski Maciej, Puchalski Zbigniew, Kinalska Ida
Abstract excerpt
Type 1 diabetes is believed to be a Th1 lymphocyte-mediated disease, and both environmental and genetic factors play a role in its pathogenesis. It was recently found that interleukin (IL)-18 acts as a proinflammatory cytokine and, in synergy with IL-12, promotes development of Th1 lymphocyte response by induction of gamma-interferon production. The aim of our study was to evaluate the frequency of known...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
